Brown’s Giuliani RNA Center and the Rhode Island Life Science Hub co-hosted a symposium focused on how scientists can work together to turn RNA discoveries into solutions. PROVIDENCE, R.I. [Brown ...

mRNA Vaccines dominated the market in 2024, accounting for over US$ 36 billion in revenues. Pfizer, Moderna, and BioNTech continue to lead this space, expanding indications beyond infectious diseases ...

Corn rootworms, pests responsible for billions of dollars in yearly crop losses, are evolving resistance that weakens even the latest biotechnology controls, according to a new study published in the ...

From more than 30 target action dates in the last three months of the year, BioSpace has narrowed the list to six regulatory decisions that could have far-reaching implications for biopharma and ...

Oceans churned with lava. Air filled thick with smoke. Asteroids stormed down incessantly. Life during the Hadean Eon four billion years ago was a struggle, and yet that was when it began. 1,2 With no ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. While undeniably bold, the SpaceX Starship ...

The investment from Brown parents Giammaria and Sabrina Giuliani will support scholars seeking to unlock the potential of RNA to make a positive impact on human health.

To solve a problem, scientists first need to see it clearly. Whether it’s a virus slipping past the immune system or plaques forming in the brain, visualization is the first step toward finding ...

The U.S. Environmental Protection Agency has approved the registration of Norroa, the first-ever RNA-based treatment for varroa mites.

RNA therapies have emerged as a transformative modality across vaccines, cancer immunotherapy, and gene editing. Novel delivery vehicles that can protect ...